Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(0)
# 4367
Out of 5,267 analysts
387
Total ratings
29.05%
Success rate
-10.41%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Vir Biotechnology | Reiterates: Buy | 110 110 | 8.39 | 1211.08% | 23 | Feb 28, 2025 | |
Immunocore Holdings | Reiterates: Buy | 100 100 | 29.41 | 240.02% | 18 | Feb 28, 2025 | |
Beam Therapeutics | Reiterates: Buy | 80 80 | 26.27 | 204.53% | 6 | Feb 28, 2025 | |
Milestone Pharmaceut... | Reiterates: Buy | 25 25 | 1.62 | 1443.21% | 16 | Feb 28, 2025 | |
Harmony Biosciences ... | Maintains: Buy | 75 70 | 33.83 | 106.92% | 5 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Strong Buy | 400 500 | 247.62 | 101.92% | 25 | Feb 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 1.14 | 777.19% | 16 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 60 60 | 5.44 | 1002.94% | 15 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 85 85 | 37.24 | 128.25% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 1.72 | 481.4% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 190 150 | 8.16 | 1738.24% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 40 40 | 3.92 | 920.41% | 13 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 80 80 | 18.91 | 323.06% | 22 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 12 12 | 6.66 | 80.18% | 14 | Feb 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 75 75 | 4.48 | 1574.11% | 22 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 5 | 0.65 | 669.23% | 16 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 55 55 | 6.73 | 717.24% | 17 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 1.22 | 719.67% | 15 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 30 30 | 4.07 | 637.1% | 7 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 25 70 | 13.17 | 431.51% | 12 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 40 40 | 10.18 | 292.93% | 14 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 1.01 | 890.1% | 24 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 80 60 | n/a | n/a | 14 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 15 7 | n/a | n/a | 8 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 360 | n/a | n/a | 5 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | n/a | n/a | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 20 | n/a | n/a | 1 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 3 | n/a | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | n/a | n/a | 1 | Oct 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 170 68 | 12.65 | 437.55% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 7 | n/a | n/a | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 120 100 | n/a | n/a | 3 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 230 20 | 0.28 | 7042.86% | 2 | Dec 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 500 625 | n/a | n/a | 2 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 10 | n/a | n/a | 3 | Oct 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 260 340 | 296.81 | 14.55% | 1 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | n/a | n/a | 1 | Jul 26, 2021 |